Denali Therapeutics Inc. Uncategorized Contracts & Agreements
11 Contracts & Agreements
- Denali - Biogen Side Letter (Filed With SEC on August 1, 2024)
- Denali Insider Trading Policy and Guidelines with Respect to Certain Transactions in Securities as amended through March 31, 2023 (Filed With SEC on February 28, 2024)
- Nominating Agreement by and among the Company and Investor (Filed With SEC on February 27, 2024)
- Side Letter between the Registrant and F-star Gamma Limited, dated June 30, 2021 (Filed With SEC on August 4, 2021)
- Definitive R (Filed With SEC on November 5, 2020)
- Side Letter between the Registrant, F-Star Gamma Limited, F-Star Biotechnology Limited and f-star Biotechnologische Forschungs-und Entwicklungsges m.b.H., dated May 21, 2018 (Filed With SEC on August 9, 2018)
- Amended and Restated Licence Agreement between F-star Gamma Limited and F-star Biotechnology Limited, dated August 24, 2016 (Filed With SEC on August 9, 2018)
- Offer Letter between the Registrant and Carole Ho, M.D., dated November 10, 2017 (Filed With SEC on November 13, 2017)
- Offer Letter between the Registrant and Steve E. Krognes, dated November 10, 2017 (Filed With SEC on November 13, 2017)
- Offer Letter between the Registrant and Alexander O. Schuth, M.D., dated November 10, 2017 (Filed With SEC on November 13, 2017)
- Offer Letter between the Registrant and Ryan J. Watts, Ph.D., dated November 10, 2017 (Filed With SEC on November 13, 2017)
